Biology and therapeutic potential of interleukin-10

M Saraiva, P Vieira, A O'garra - Journal of Experimental Medicine, 2019 - rupress.org
The cytokine IL-10 is a key anti-inflammatory mediator ensuring protection of a host from
over-exuberant responses to pathogens and microbiota, while playing important roles in …

LPS-induced cytokine production in human monocytes and macrophages

M Rossol, H Heine, U Meusch, D Quandt… - Critical Reviews™ in …, 2011 - dl.begellhouse.com
Lipopolysaccharide (LPS) from Gram-negative bacteria is one of the most potent innate
immune-activating stimuli known. Here we review the current understanding of LPS effects …

Interferon-dependent IL-10 production by Tregs limits tumor Th17 inflammation

CA Stewart, H Metheny, N Iida, L Smith… - The Journal of …, 2013 - Am Soc Clin Investig
The capacity of IL-10 and Tregs in the inflammatory tumor microenvironment to impair
anticancer Th1 immunity makes them attractive targets for cancer immunotherapy. IL-10 and …

The specific roles of JAK/STAT signaling pathway in sepsis

B Cai, J Cai, Y Luo, C Chen, S Zhang - Inflammation, 2015 - Springer
The Janus kinase-signal transducer and activator of transcription (JAK/STAT) pathway is a
principal signaling pathway for the signal transduction of many pivotal cytokines involved in …

STAT1-regulated lung MDSC-like cells produce IL-10 and efferocytose apoptotic neutrophils with relevance in resolution of bacterial pneumonia

SL Poe, M Arora, TB Oriss, M Yarlagadda, K Isse… - Mucosal …, 2013 - nature.com
Bacterial pneumonia remains a significant burden worldwide. Although an inflammatory
response in the lung is required to fight the causative agent, persistent tissue-resident …

[HTML][HTML] Reprogramming of tumor-associated macrophages by polyaniline-coated iron oxide nanoparticles applied to treatment of breast cancer

C Nascimento, F Castro, M Domingues, A Lage… - International Journal of …, 2023 - Elsevier
Breast cancer is the most commonly diagnosed type of cancer among the female population
worldwide. It is a disease with a high incidence and geographic distribution that negatively …

Myeloid-derived suppressor cells as an immune parameter in patients with concurrent sunitinib and stereotactic body radiotherapy

HM Chen, G Ma, N Gildener-Leapman… - Clinical Cancer …, 2015 - AACR
Purpose: The clinical effects of sunitinib on human myeloid-derived suppressor cell (MDSC)
subsets and correlation of the T-cell–mediated immune responses and clinical outcomes in …

Interleukin-10: A double-edged sword in breast cancer

CM Chang, HYP Lam, HJ Hsu, SJ Jiang - Tzu chi medical journal, 2021 - journals.lww.com
Breast cancer (BC) is a frequently diagnosed cancer among women worldwide. Currently,
BC can be divided into different subgroups according to the presence of the following …

Interleukin-10-induced neutrophil gelatinase-associated lipocalin production in macrophages with consequences for tumor growth

M Jung, A Weigert, M Tausendschön… - … and cellular biology, 2012 - Taylor & Francis
Tumor cell-derived factors, such as interleukin 10 (IL-10), polarize macrophages toward a
regulatory M2 phenotype, characterized by the expression of anti-inflammatory cytokines …

Role of Janus kinase/signal transducer and activator of transcription pathway in regulation of expression and inflammation-promoting activity of high mobility group …

H Liu, YM Yao, Y Yu, N Dong, HN Yin, ZY Sheng - Shock, 2007 - journals.lww.com
Signal transduction mechanism in the regulation of high mobility group box protein 1
(HMGB1) has not yet been well elucidated. Our data showed for the first time that Janus …